ArticleNeurocritical care2020
Reply to "Key Points to Consider When Evaluating Andexxa for Formulary Addition".
Charles E MahanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
2020
this papercites it
ArticleNeurocritical care2020
Charles E MahanPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.